Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-19

Clinical Trial Update: Improving Glare and Visual Comfort for Patients With Visual Impairment [NA]

View source ↗

Summary

A clinical trial evaluating glare reduction and visual comfort for patients with visual impairment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nova Southeastern University | Conditions: Photophobia, Visual Impairment | NA | Status: WITHDRAWN